Dynamic prediction of Radiotherapy toxicities in Head and neck cancer using clinical and imaging data.

Bang, C; Gautier, H; Le, W T; Lalonde, A; Bernard, G; Markel, D; Nguyen-Tan, F; Filion, E et al. · Radiother Oncol · 2026

retrospective_cohort · Level III

Where this comes from

Abstract

Head and neck cancer (HNC) radiotherapy (RT) is effective but causes significant toxicity. We aimed to develop a dynamic deep learning model to predict three major HNC RT toxicities-nasogastric (NG) tube placement, hospitalization, and radionecrosis-by integrating clinical data and daily cone-beam computed tomography (CBCTs), assessing whether serial imaging or dosimetry features improve early prediction. We retrospectively analyzed 1,012 HNC patients treated with RT between 2017 and 2022. A multibranch 3D ResNet50 and multilayer perceptron model was trained using 5-fold cross-validation. Inputs included anatomical deformations from daily CBCTs (converted to Jacobian determinant matrices, J<sub>f</sub>), radiomics, and clinical variables (demographics, tumor and treatment details, early weight loss). Each toxicity was modeled using weighted binary cross-entropy loss to address class imbalance. Prediction at the 10th RT fraction was compared with and without J<sub>f</sub> integration. The cohort was 78% male, median age was 63 years (range 35-84). Primary sites were mainly oropharynx (47%), larynx (19%), and oral cavity (16%). Concurrent chemoradiation was given to 57%, induction chemotherapy to 7%, and postoperative RT to 18% of patients. Incidences of NG tube, hospitalization, and radionecrosis were 16.6%, 4.2%, and 4.6%, respectively. Clinical features alone yielded highest predictive accuracy: 70% for NG tube, 67.3% for hospitalization, and 74.2% for radionecrosis. Early weight loss was the strongest predictor. Early J<sub>f</sub> or radiomics did not improve performance. NG tube prediction accuracy improved with later RT fractions (up to 75% at fraction 25). Clinical data combined with weight loss remains the most reliable early predictor of toxicity without added benefit from imaging data.

Medical subject headings